ELV Elevance Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELV

Price (delayed)

$413.75

Market cap

$89.39B

P/E Ratio

17.52

Dividend/share

$6.87

EPS

$23.62

Enterprise value

$109.8B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 44

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – ...

Highlights
ELV's gross profit is up by 6% year-on-year and by 2.7% since the previous quarter
Elevance Health's debt has decreased by 4.2% YoY
Elevance Health's net income has decreased by 7% YoY but it has increased by 3.5% QoQ
Elevance Health's EPS has increased by 4.3% QoQ but it has decreased by 3.9% YoY
ELV's P/E is 18% above its last 4 quarters average of 14.9
ELV's quick ratio is down by 6% year-on-year and by 2.9% since the previous quarter
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.antheminc.com
Peers: OSCR PFG

Key stats

What are the main financial stats of ELV

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
0.04%
1 week
-1.84%
1 month
7.07%
1 year
32.11%
YTD
18.03%
QTD
6.41%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$201.83B
Gross profit
$31.23B
Operating income
$7.7B
Net income
$5.14B
Gross margin
15.5%
Net margin
2.5%
The operating margin has declined by 14% year-on-year but it is up by 6% since the previous quarter
Elevance Health's net margin has decreased by 11% YoY
The operating income has contracted by 9% YoY but it has grown by 5% from the previous quarter
Elevance Health's net income has decreased by 7% YoY but it has increased by 3.5% QoQ

Price vs fundamentals

How does ELV's price correlate with its fundamentals

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
ELV P/E details
P/E
17.52
P/B
2.01
P/S
0.44
EV/EBIT
14.2
EV/EBITDA
11.91
EV/Sales
0.54
ELV's P/E is 18% above its last 4 quarters average of 14.9
Elevance Health's EPS has increased by 4.3% QoQ but it has decreased by 3.9% YoY
ELV's price to book (P/B) is 23% lower than its 5-year quarterly average of 2.6 but 12% higher than its last 4 quarters average of 1.8
ELV's P/S is 27% below its 5-year quarterly average of 0.6 but 10% above its last 4 quarters average of 0.4
The company's revenue rose by 3.6% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's return on sales has decreased by 14% YoY but it has increased by 6% QoQ
Elevance Health's ROIC has decreased by 12% YoY but it has increased by 7% from the previous quarter
Elevance Health's return on assets has decreased by 11% YoY but it has increased by 2.5% QoQ
ELV's ROE is down by 10% YoY but it is up by 3.6% QoQ

Dividends

What is ELV's dividend history
Dividend details
DPS
$6.87
Dividend yield
1.66%
Payout ratio
29.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Elevance Health financials performed over time
The total assets is 54% higher than the total liabilities
The current ratio fell by 6% YoY and by 3.3% QoQ
ELV's quick ratio is down by 6% year-on-year and by 2.9% since the previous quarter
Elevance Health's debt is 31% less than its equity
The debt to equity has declined by 5% year-on-year
Elevance Health's debt has decreased by 4.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.